Ovation

Ovation, founded in 2009, is a prominent player in the Cloud Infrastructure and Enterprise Software industries. The company's mission to unlock the potential of human genomic data to accelerate precision medicine is clearly reflected in its activities. Ovation offers an extensive collection of high-quality genomic data interconnected with diverse, longitudinal phenotypic data on a large scale, aimed at advancing precision medicine. This data not only aids in the identification and validation of biomarkers but also facilitates the discovery of new targets and comprehension of resistance mechanisms across varied populations.

The most recent investment in Ovation amounted to a substantial $21.50M Series B round, which took place on 16 December 2020. This round of funding attracted contributions from distinguished investors including Madrona, SignalFire, Borealis Ventures, StageDotO, Black Point Group, and David Shaw.

Ovation's cloud-based Laboratory Information Management System (LIMS) has transformed the landscape for clinical labs by enabling the effortless adoption of innovative molecular tests. Moreover, it facilitates the conversion of samples into valuable research-grade data across various disease areas. The company's commitment to revolutionizing the accessibility of consented genomic data for research purposes is evident in its efforts, driving significant impact in the life sciences industry. For more details, visit www.ovation.io.